dostarlimab
gsk
['rectal', 'dostarlimab']
#asco22 results that will change the treatment of rectal cancer!! 14 patients with stage 2 or 3 rectal cancer and dmmr
neoadjuvant dostarlimab ccr 100% the follow-up time is short but the results are excellent! 
Medical Oncologist